Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Hutzen

Showing results (1-10 of 25) with videos related to

Pageof 3
Sort By:
Oncolytic Virotherapy|August 12, 2016
Advances in the design and development of oncolytic measles virusesBrian Hutzen, Corey Raffel, Adam W Studebaker
Molecular Therapy Oncolytics|September 8, 2023
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?Siddhi N Paudel, Brian Hutzen, Timothy P Cripe
Oncolytic Virotherapy|August 15, 2018
Oncolytic virus and PD-1/PD-L1 blockade combination therapyChun-Yu Chen, Brian Hutzen, Mary F Wedekind, et al.
Cancer Cell International|August 29, 2009
Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cellsBrian Hutzen, William Willis, Sarah Jones, et al.
Neuro-Oncology|February 7, 2012
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastomaAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
BMC Cancer|November 9, 2012
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodineBrian Hutzen, Christopher R Pierson, Stephen J Russell, et al.
Neuro-Oncology|April 4, 2015
Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumorsAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
Cancer Metastasis Reviews|December 13, 2019
Immunotherapies for pediatric cancer: current landscape and future perspectivesBrian Hutzen, Siddhi Nath Paudel, Meisam Naeimi Kararoudi, et al.
BMC Cancer|March 21, 2014
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatinBrian Hutzen, Hemant Kumar Bid, Peter J Houghton, et al.
International Journal of Oncology|September 3, 2009
Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomasBrian Hutzen, Lauren Friedman, Matthew Sobo, et al.
Pageof 3

Showing results (1-10 of 25) with videos related to

Sort By:
Pageof 3
Oncolytic Virotherapy|August 12, 2016
Advances in the design and development of oncolytic measles virusesBrian Hutzen, Corey Raffel, Adam W Studebaker
Molecular Therapy Oncolytics|September 8, 2023
The quest for effective immunotherapies against malignant peripheral nerve sheath tumors: Is there hope?Siddhi N Paudel, Brian Hutzen, Timothy P Cripe
Oncolytic Virotherapy|August 15, 2018
Oncolytic virus and PD-1/PD-L1 blockade combination therapyChun-Yu Chen, Brian Hutzen, Mary F Wedekind, et al.
Cancer Cell International|August 29, 2009
Dietary agent, benzyl isothiocyanate inhibits signal transducer and activator of transcription 3 phosphorylation and collaborates with sulforaphane in the growth suppression of PANC-1 cancer cellsBrian Hutzen, William Willis, Sarah Jones, et al.
Neuro-Oncology|February 7, 2012
Oncolytic measles virus prolongs survival in a murine model of cerebral spinal fluid-disseminated medulloblastomaAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
BMC Cancer|November 9, 2012
Treatment of medulloblastoma using an oncolytic measles virus encoding the thyroidal sodium iodide symporter shows enhanced efficacy with radioiodineBrian Hutzen, Christopher R Pierson, Stephen J Russell, et al.
Neuro-Oncology|April 4, 2015
Oncolytic measles virus efficacy in murine xenograft models of atypical teratoid rhabdoid tumorsAdam W Studebaker, Brian Hutzen, Christopher R Pierson, et al.
Cancer Metastasis Reviews|December 13, 2019
Immunotherapies for pediatric cancer: current landscape and future perspectivesBrian Hutzen, Siddhi Nath Paudel, Meisam Naeimi Kararoudi, et al.
BMC Cancer|March 21, 2014
Treatment of medulloblastoma with oncolytic measles viruses expressing the angiogenesis inhibitors endostatin and angiostatinBrian Hutzen, Hemant Kumar Bid, Peter J Houghton, et al.
International Journal of Oncology|September 3, 2009
Curcumin analogue GO-Y030 inhibits STAT3 activity and cell growth in breast and pancreatic carcinomasBrian Hutzen, Lauren Friedman, Matthew Sobo, et al.
Pageof 3